Plant stanol eaters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner

被引:153
作者
Hallikainen, MA [1 ]
Sarkkinen, ES [1 ]
Uusitupa, MIJ [1 ]
机构
[1] Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland
关键词
plant stanol ester; plant sterol; sitostanol; cholesterol; humans;
D O I
10.1093/jn/130.4.767
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The effect of plant stanol ester on serum cholesterol is dose-dependent. However, it is not clear what the dose is beyond which no additional benefit can be obtained. Therefore, we determined the dose-response relationship for serum cholesterol with different doses of plant stanol ester in hypercholesterolemic subjects. In a single-blind design each of 22 men or women consumed five different doses of plant stanol [target (actual) intake 0 (0), 0.8 (0.8), 1.6 (1.6), 2.4 (2.3), 3.2 3.0) g/d] added as plant stanol esters to margarine for 4 wk. The order of dose periods was randomly determined. Serum total cholesterol concentration decreased (calculated in reference to control) by 2.8% (P = 0.384), 6.8% (P < 0.001), 10.3% (P < 0.001) and 11.3% (P < 0.001) by doses from 0.8 to 3.2 g. The respective decreases for LDL cholesterol were 1.7% (P = 0.892), 5.6% (P < 0.05), 9.7% (P < 0.001) and 10.4% (P < 0.001). Although the decreases were numerically greater with 2.4 and 3.2 g doses than with the 1.6 g dose, these differences were not significant (P = 0.054-0.516). Serum plant stanols rose slightly, but significantly with the dose (P < 0.001). Apolipoprotein B concentration was decreased significantly already at the dose of 0.8 g (8.7%, P < 0.001). Apolipoprotein E genotype did not affect the lipid responses. We conclude that significant reduction of serum total and LDL cholesterol concentrations is reached with the 1.6-g stanol dose, and increasing the dose from 2.4 to 3.2 g does not provide clinically important additional effect.
引用
收藏
页码:767 / 776
页数:10
相关论文
共 40 条
[1]  
ALPERS DH, 1986, MANUAL NUTR THERAPEU, P131
[2]   TREATMENT OF SEVERE FAMILIAL HYPERCHOLESTEROLEMIA IN CHILDHOOD WITH SITOSTEROL AND SITOSTANOL [J].
BECKER, M ;
STAAB, D ;
VONBERGMANN, K .
JOURNAL OF PEDIATRICS, 1993, 122 (02) :292-296
[3]   VARIATIONS IN PLASMA-VOLUME AFFECT TOTAL AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL CONCENTRATIONS DURING THE MENSTRUAL-CYCLE [J].
CULLINANE, EM ;
YURGALEVITCH, SM ;
SARITELLI, AL ;
HERBERT, PN ;
THOMPSON, PD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (08) :965-971
[4]  
DRISKELL WJ, 1983, CLIN CHEM, V29, P1042
[5]   THE EFFECT OF BETA SITOSTEROL ON THE SERUM LIPIDS OF YOUNG MEN WITH ARTERIOSCLEROTIC HEART DISEASE [J].
FARQUHAR, JW ;
SMITH, RE ;
DEMPSEY, ME .
CIRCULATION, 1956, 14 (01) :77-82
[6]  
Gylling H, 1997, CIRCULATION, V96, P4226
[7]   SERUM-CHOLESTEROL AND CHOLESTEROL AND LIPOPROTEIN METABOLISM IN HYPERCHOLESTEROLEMIC NIDDM PATIENTS BEFORE AND DURING SITOSTANOL ESTER-MARGARINE TREATMENT [J].
GYLLING, H ;
MIETTINEN, TA .
DIABETOLOGIA, 1994, 37 (08) :773-780
[8]  
GYLLING H, 1995, J LIPID RES, V36, P1807
[9]  
Gylling H, 1999, J LIPID RES, V40, P593
[10]  
GYLLING HK, 1996, CIRCULATION S1, V94, P578